Current molecular biomarkers evaluation in gastric/gastroesophageal junction adenocarcinoma: pathologist does matter

被引:0
作者
Gianluca Businello
Valentina Angerilli
Sara Lonardi
Francesca Bergamo
Michele Valmasoni
Fabio Farinati
Edoardo Savarino
Gaya Spolverato
Matteo Fassan
机构
[1] University of Padua,Department of Medicine (DIMED)
[2] Veneto Institute of Oncology,Department of Surgery, Oncology and Gastroenterology (DISCOG)
[3] Istituto Di Ricovero E Cura a Carattere Scientifico (IRCCS),undefined
[4] University of Padua,undefined
来源
Updates in Surgery | 2023年 / 75卷
关键词
Gastric adenocarcinoma; Gastroesophageal junction adenocarcinoma; Biomarkers; Immunohistochemistry;
D O I
暂无
中图分类号
学科分类号
摘要
The comprehensive molecular characterization of gastric and gastroesophageal junction adenocarcinomas has led to the improvement of targeted and more effective treatments. As a result, several biomarkers have been introduced into clinical practice and the implementation of innovative diagnostic tools is under study. Such assessments are mainly based on the evaluation of limited biopsy material in clinical practice. In this setting, the pathologist represents a key player in the selection of patients facilitating precision medicine approaches.
引用
收藏
页码:291 / 303
页数:12
相关论文
共 628 条
  • [1] Sung H(2021)Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries CA Cancer J Clin 71 209-249
  • [2] Ferlay J(2010)Age-specific trends in incidence of noncardia gastric cancer in US adults JAMA 303 1723-1728
  • [3] Siegel RL(2020)Precancerous lesions of the stomach, gastric cancer and hereditary gastric cancer syndromes Pathologica 112 166-185
  • [4] Laversanne M(2010)Meta-analysis: the association of oesophageal adenocarcinoma with symptoms of gastro-oesophageal reflux Aliment Pharmacol Ther 32 1222-1227
  • [5] Soerjomataram I(1965)The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. an attempt at a histo-clinical classification Acta Pathol Microbiol Scand 64 31-49
  • [6] Jemal A(2021)Molecular landscapes of gastric pre-neoplastic and pre-invasive lesions Int J Mol Sci 22 9950-209
  • [7] Anderson WF(2014)Comprehensive molecular characterization of gastric adenocarcinoma Nature 513 202-5788
  • [8] Camargo MC(2019)Targeted therapies in metastatic gastric cancer: current knowledge and future perspectives World J Gastroenterol 25 5773-259
  • [9] Fraumeni JF(2020)Current prognostic and predictive biomarkers for gastrointestinal tumors in clinical practice Pathologica 112 248-933
  • [10] Correa P(2007)Is gastric cancer part of the tumour spectrum of hereditary non-polyposis colorectal cancer? A molecular genetic study Gut 56 926-16442